Expression of Concern: Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small cell lung cancer cells. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.